NCT00708903已完成1 期
A Single Dose, Crossover, Placebo- and Moxifloxacin-Controlled Study of the Effects of HKI-272 on Cardiac Repolarization in Healthy Adult Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 60
- 主要终点
- QTc interval
研究概览
简要总结
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men or women of nonchildbearing potential,
- •18-50 years old.
- •Healthy as determined by the investigator, including physical examination, laboratory test results, and medical history.
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
HKI-272
干预措施: neratinib (Drug)
2
Placebo Comparator
Placebo
干预措施: Placebo (Other)
3
Active Comparator
Moxifloxacin
干预措施: Moxifloxacin (Drug)
结局指标
主要结局
QTc interval
时间窗: 3 days
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)Healthy SubjectsNCT00914121Wyeth is now a wholly owned subsidiary of Pfizer60
已完成
1 期
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy SubjectsHealthyNCT00434395Bausch Health Americas, Inc.
已完成
1 期
A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerAdvanced Malignant Solid TumorsBreast NeoplasmsAdvanced Breast CancerNCT00445458Puma Biotechnology, Inc.110
已完成
1 期
Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control ValidationQTc EvaluationElectrocardiographyNCT01014247Bayer56
招募中
1 期
A Study to Evaluate the Effects of HSK3486 Administration on Cardiac Repolarization in Healthy SubjectsAnesthesiaNCT06379867Haisco Pharmaceutical Group Co., Ltd.48